Yüklüyor......
Evaluation of Cerebral Perfusion in Patients Undergoing Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis
Currently, the indication for thrombolytic therapy using intravenous recombinant tissue plasminogen activator (rt-PA) is restricted strictly to patients with acute ischemic stroke within 4.5 h of onset. The effect of rt-PA declines over time; therefore, we need to minimize the time delay while gener...
Kaydedildi:
| Yayımlandı: | Neurol Med Chir (Tokyo) |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
The Japan Neurosurgical Society
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4663028/ https://ncbi.nlm.nih.gov/pubmed/26369875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2176/nmc.ra.2015-0111 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|